Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Natalizumab
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Natalizumab 300mg/15ml solution for infusion vials
0802040W0AAAAAA
|
Natalizumab | Natalizumab | Malignant Disease and Immunosuppression | No data available |
|
Tyruko 300mg/15ml concentrate for inf vials
0802040W0BCAAAA
|
Tyruko | Natalizumab | Malignant Disease and Immunosuppression | No data available |
|
Tysabri 300mg/15ml concentrate for inf vials
0802040W0BBAAAA
|
Tysabri | Natalizumab | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.